VU 0255035

Known as: VU-0255035, VU0255035 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2009-2016
012320092016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
The dorsolateral striatum is critically involved in movement control and motor learning. Striatal function is regulated by a… (More)
Is this relevant?
2017
2017
Enhancement of cholinergic function via muscarinic acetylcholine receptor M1 agonism improves cognition in some schizophrenia… (More)
Is this relevant?
2015
2015
Clinical studies demonstrate that scopolamine, a non-selective muscarinic acetylcholine receptor (mAchR) antagonist, produces… (More)
Is this relevant?
2015
2015
The role of muscarinic receptor subtypes in modulating acute liver injury is unknown. We detected M1 muscarinic receptor (M1R… (More)
Is this relevant?
2015
2015
BACKGROUND AND PURPOSE Activation of muscarinic receptors results in catecholamine secretion in adrenal chromaffin cells in many… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 3
  • figure 4
Is this relevant?
2014
2014
Scopolamine produces rapid and significant symptom improvement in patients with depression, and most notably in patients who do… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2014
2014
Broad-spectrum muscarinic receptor antagonists have represented the first available treatment for different movement disorders… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2014
2014
Scopolamine produces rapid and significant symptom improvement in patients with depression, and most notably in patients who do… (More)
  • figure 1
  • figure 2
  • table 1
  • table 2
  • figure 3
Is this relevant?
2012
2012
Antagonists of the muscarinic acetylcholine receptors (mAChRs) were among the first treatments for Parkinson's disease. However… (More)
  • figure 1
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2009
2009
Previous studies suggest that selective antagonists of specific subtypes of muscarinic acetylcholine receptors (mAChRs) may… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?